InvestSMART

Cyclopharm Limited (ASX: CYC) - Announcements

Current share price for CYC : $0.600 0.025 (4.35%)+

ASX company news and announcements for Cyclopharm Limited (CYC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cyclopharm Limited (CYC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cyclopharm Limited (CYC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cyclopharm Limited (CYC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$75 Immediate 11-Site Technegas Rollout at University Hospitals 15 Jul 2026 8:29AM $0.485 $0.600 risen by 23.71%
$75 Notification of cessation of securities - CYC 6 Jul 2026 3:05PM $0.515 $0.600 risen by 16.50%
$75 CYC First-Half 2026 Update 2 Jul 2026 10:11AM $0.510 $0.600 risen by 17.65%
$75 Change in substantial holding 25 Jun 2026 5:19PM $0.500 $0.600 risen by 20%
$75 Final Director's Interest Notice - KB 8 May 2026 2:32PM $0.795 $0.600 fallen by 24.53%
$75 Final Director's Interest Notice - DH 8 May 2026 2:31PM $0.795 $0.600 fallen by 24.53%
$75 Results of Meeting 8 May 2026 2:28PM $0.790 $0.600 fallen by 24.05%
$75 CYC 2026 AGM Presentation 8 May 2026 10:14AM $0.745 $0.600 fallen by 19.46%
$75 Managing Director's Address to Shareholders 8 May 2026 10:12AM $0.745 $0.600 fallen by 19.46%
$75 Chair's Address to Shareholders 8 May 2026 10:11AM $0.745 $0.600 fallen by 19.46%
$75 Appointment of Non-Executive Director and Incoming Chair 4 May 2026 9:51AM $0.725 $0.600 fallen by 17.24%
$75 Initial Director's Interest Notice - DC 4 May 2026 9:47AM $0.725 $0.600 fallen by 17.24%
$75 Change in substantial holding 22 Apr 2026 9:03AM $0.750 $0.600 fallen by 20%
$75 Cleansing Notice 20 Apr 2026 1:09PM $0.725 $0.600 fallen by 17.24%
$75 Application for quotation of securities - CYC 20 Apr 2026 12:57PM $0.725 $0.600 fallen by 17.24%
$75 AGM - Supplementary Disclosure 20 Apr 2026 10:42AM $0.720 $0.600 fallen by 16.67%
$75 Notice of Annual General Meeting/Proxy Form 10 Apr 2026 11:18AM $0.830 $0.600 fallen by 27.71%
$75 Final Director's Interest Notice - JW 7 Apr 2026 10:26AM $0.855 $0.600 fallen by 29.82%
$75 Resignation of Non-Executive Director John Wigglesworth 7 Apr 2026 10:24AM $0.855 $0.600 fallen by 29.82%
$75 USA Technegas Expansion Update 31 Mar 2026 8:42AM $0.750 $0.600 fallen by 20%
$75 Appendix 4G and Corporate Governance Statement 27 Mar 2026 4:56PM $0.750 $0.600 fallen by 20%
$75 Annual Report to shareholders 27 Mar 2026 4:53PM $0.750 $0.600 fallen by 20%
$75 CYC Secures Multi-Site Agreement with Northwestern Medicine 24 Mar 2026 8:28AM $0.750 $0.600 fallen by 20%
$75 CYC Signs Enterprise Agreement with UPHS 23 Mar 2026 9:16AM $0.720 $0.600 fallen by 16.67%
$75 Change of Director's Interest Notice - KB 12 Mar 2026 1:19PM $0.755 $0.600 fallen by 20.53%

1 - 25 of 607 results

Page 1 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.